Cargando…
Efficacy of Antiviral Treatment in Liver Biopsy-Proven Immune-Tolerant Chronic Hepatitis B Patients: A Retrospective Cohort Study
The optimal timing of initiating antiviral treatment for immune-tolerant (IT) patients remains unknown. We conducted this study in liver biopsy-proven IT patients to compare the long-term outcomes of untreated and treated patients suffering non-cirrhotic chronic hepatitis B (CHB). This retrospective...
Autores principales: | Liu, Na, Yang, Nan, Ma, Wenqi, Yang, Shujuan, Hu, Chunhua, Li, Juan, Zhao, Yingren, Xu, Guanghua, He, Yingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060436/ https://www.ncbi.nlm.nih.gov/pubmed/33898489 http://dx.doi.org/10.3389/fmed.2021.655530 |
Ejemplares similares
-
Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease
por: Sun, Qing-Feng, et al.
Publicado: (2022) -
Histopathological and Clinical Findings of Biopsy-Proven Focal and Segmental Glomerulosclerosis: A Retrospective Study
por: Alhozali, Hanadi M, et al.
Publicado: (2022) -
A Perplexing Case of Bladder Mass Biopsy-Proven Neurosarcoidosis
por: Hanif, Zainab, et al.
Publicado: (2023) -
A Curious Case of Biopsy-Proven Usual Interstitial Pneumonia
por: Makadia, Austin, et al.
Publicado: (2023) -
Incidence of biopsy-proven giant cell arteritis (GCA) in South Australia 2014–2020
por: Ninan, Jem, et al.
Publicado: (2023)